Novavax (NVAX) EPS (Basic) (2010 - 2026)
Novavax's (NVAX) quarterly EPS (Basic) came in at -$0.06 in Q1 2026, down 101.8% year-on-year from $3.22 in Q1 2025, and down 153.72% quarter-over-quarter from $0.11 in Q4 2025.
Novavax (NVAX) EPS (Basic) (2010 - 2026) Analysis & Trends
Novavax's EPS (Basic) history runs 17 years deep, the most recent figure standing at -$0.06 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 101.8% year-over-year to -$0.06 in Q1 2026; TTM through Mar 2026 was -$0.54, a 118.1% decrease from a year earlier, with the FY2025 full-year figure at $2.72, up 320.62% from the prior year.
- EPS (Basic) fell to -$0.06 in Q1 2026 per NVAX's latest filing, from $0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.22 in Q1 2025 and bottomed at -$6.53 in Q2 2022.
- The 5-year median for EPS (Basic) is -$0.76 (2024), against an average of -$0.75.
- Across the five-year window, EPS (Basic) plunged 228.22% in 2023 and jumped 405.38% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$2.33 in 2022, then rose by 24.06% to -$1.77 in 2023, then jumped by 69.92% to -$0.53 in 2024, then jumped by 120.32% to $0.11 in 2025, then slumped by 153.72% to -$0.06 in 2026.
- Per Business Quant, the three latest NVAX EPS (Basic) figures stand at -$0.06 (Q1 2026), $0.11 (Q4 2025), and -$1.25 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Novavax | 1.23 Bn | 435.05 Mn | 108.82 Mn | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.06 |
| Dec 31, 2025 | 0.11 |
| Sep 30, 2025 | -1.25 |
| Jun 30, 2025 | 0.66 |
| Mar 31, 2025 | 3.22 |
| Dec 31, 2024 | -0.53 |
| Sep 30, 2024 | -0.76 |
| Jun 30, 2024 | 1.09 |
| Mar 31, 2024 | -1.05 |
| Dec 31, 2023 | -1.77 |
| Sep 30, 2023 | -1.26 |
| Jun 30, 2023 | 0.65 |
| Mar 31, 2023 | -3.41 |
| Dec 31, 2022 | -2.33 |
| Sep 30, 2022 | -2.15 |
| Jun 30, 2022 | -6.53 |
| Mar 31, 2022 | 2.66 |
| Dec 31, 2021 | -11.37 |
| Sep 30, 2021 | -4.31 |
| Jun 30, 2021 | -4.75 |